Advertisement
Advertisement
U.S. markets open in 3 hours 34 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
48.67+1.42 (+3.01%)
At close: 04:00PM EDT
49.84 +1.17 (+2.40%)
After hours: 05:27PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/17/2022
Current
6/30/20223/31/202212/31/20219/30/20216/30/2021
Market Cap (intraday)
3.45B4.18B5.07B5.83B6.13B6.46B
Enterprise Value
2.95B3.62B4.37B5.14B5.33B5.54B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
10.1712.2914.0115.6316.3218.01
Price/Book (mrq)
5.095.245.496.256.306.13
Enterprise Value/Revenue
8.8240.4954.6761.6265.2863.72
Enterprise Value/EBITDA
-6.35-24.56-30.98-44.64-87.50-50.23

Trading Information

Stock Price History

Beta (5Y Monthly) 1.21
52-Week Change 3-41.06%
S&P500 52-Week Change 3-3.56%
52 Week High 3104.38
52 Week Low 345.20
50-Day Moving Average 355.63
200-Day Moving Average 367.34

Share Statistics

Avg Vol (3 month) 3686.29k
Avg Vol (10 day) 3752.07k
Shares Outstanding 570.04M
Implied Shares Outstanding 6N/A
Float 866.69M
% Held by Insiders 15.00%
% Held by Institutions 194.23%
Shares Short (Jul 28, 2022) 42.84M
Short Ratio (Jul 28, 2022) 43.52
Short % of Float (Jul 28, 2022) 45.14%
Short % of Shares Outstanding (Jul 28, 2022) 44.05%
Shares Short (prior month Jun 29, 2022) 42.89M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin -151.34%
Operating Margin (ttm)-140.77%

Management Effectiveness

Return on Assets (ttm)-20.76%
Return on Equity (ttm)-61.32%

Income Statement

Revenue (ttm)334.31M
Revenue Per Share (ttm)4.85
Quarterly Revenue Growth (yoy)2.70%
Gross Profit (ttm)-161.75M
EBITDA -455.3M
Net Income Avi to Common (ttm)-505.94M
Diluted EPS (ttm)-6.87
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)542.8M
Total Cash Per Share (mrq)7.75
Total Debt (mrq)37.53M
Total Debt/Equity (mrq)5.53
Current Ratio (mrq)3.08
Book Value Per Share (mrq)9.69

Cash Flow Statement

Operating Cash Flow (ttm)-308.77M
Levered Free Cash Flow (ttm)-245.2M
Advertisement
Advertisement